Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$13.10 – $19.60
30% from low
Exchange
ARCX
ETN
Borrow rate
23.00%
Hard to borrow
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BDCZETRACS MarketVector Business Development Companies Liquid Index ETN | $15.07 | -0.06% | $11M | — |
| ARMGLeverage Shares 2x Long ARM Daily ETF | $39.49 | +6.26% | $41M | — |
| ASMGLeverage Shares 2x Long ASML Daily ETF | $64.84 | +10.72% | $32M | — |
| DTREFirst Trust Alerian Disruptive Technology Real Estate ETF | $42.24 | +0.00% | $15M | — |
| EPVProShares UltraShort FTSE Europe |
No one on the platform currently holds BDCZ.
No tracked institution reports a position in BDCZ as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-13 | $0.4526 | 2026-04-21 |
| 2026-01-13 | $0.3198 | 2026-01-22 |
| 2025-10-10 | $0.4458 | 2025-10-21 |
| 2025-07-14 | $0.4435 | 2025-07-22 |
| 2025-04-11 | $0.5805 | 2025-04-22 |
| 2025-01-13 | $0.3226 | 2025-01-22 |
| 2024-10-11 | $0.4499 | 2024-10-21 |
| 2024-07-15 | $0.4462 | 2024-07-23 |
| 2024-04-11 | $0.4599 | 2024-04-22 |
| 2024-01-12 | $0.4397 | 2024-01-24 |
No one on the platform has traded BDCZ yet.
| $18.25 |
| -0.82% |
| $8M |
| — |
| FTXHFirst Trust Nasdaq Pharmaceuticals ETF | $38.28 | -0.52% | $36M | — |
| GRNiPath Series B Carbon ETN | $31.51 | +0.00% | $12M | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-10-12 | $0.4437 | 2023-10-23 |
| 2023-07-13 | $0.4292 | 2023-07-24 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.